SDHAP1 and ovarian cancer: Mechanistically, SDHAP1 was shown to increase the expression of the protein eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) by acting as a decoy for miR-4465, which in turn promoted paclitaxel-induced cell death in ovarian cancer cells.179